MTOR and neoplasm: RNA-seq analysis revealed that RUNX1 was involved in various tumor-associated pathways, such as TNF, mTOR and focal adhesions, and that its downstream targets were involved in proliferation, apoptosis, invasion and epithelial-mesenchymal transition (EMT).